ABBOTINDIABSEAbbott India LtdMediumNegative
Announced Wed, 16 Apr · 10:28 IST

Intimation under Regulation 30 of the SEBI (LODR) Regulations, 2015 - Resignation letter of Senior Management Personnel of the Company.

Kmp ResignedManagement Changes View source PDF

ABBOTINDIA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Abbott India has formally submitted the resignation letter of Ms. Namita Shah, Associate Director – New Product Introduction and Therapy Area Strategy, to the stock exchange. Her resignation was effective from the close of business hours on April 15, 2025, and she is leaving to pursue opportunities outside the company. The company had earlier communicated this resignation on February 20, 2025, and is now sharing the formal letter as required under SEBI LODR regulations. Ms. Shah has confirmed there are no other material reasons for her departure beyond what was disclosed.

Likely market impact

This is a routine senior management departure for personal career reasons, not linked to any governance or performance issues. Investors are unlikely to see any material impact on the stock since she was in a strategy/NPI role rather than a top leadership position like CEO or CFO.